Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Jud

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Seminars in Arthritis and Rheumatism|December 4, 2020
Prevalence and prognostic factors for aortic dilatation in giant cell arteritis - a longitudinal studyPhilipp Jud, Nicolas Verheyen, Christian Dejaco, et al.
International Journal of Clinical Practice|February 4, 2021
Effect of short-interval rituximab and high-dose corticosteroids on kidney function in systemic sclerosis: Long-term experience of a single centreBalazs Odler, Carina Hebesberger, Lukas Hoeflechner, et al.
Frontiers in Nutrition|April 9, 2026
Association of lipid parameters with the development of disease complications in patients with limited cutaneous systemic sclerosis: a prospective exploratory cohort studyLeyla Schweiger, Andreas Meinitzer, Heimo Strohmaier, et al.
Clinical and Experimental Rheumatology|July 29, 2021
Evaluation of endothelial dysfunction and clinical events in patients with early-stage vasculopathy in limited systemic sclerosisPhilipp Jud, Andreas Meinitzer, Heimo Strohmaier, et al.
Frontiers in Medicine|July 10, 2023
Association of amino acids and parameters of bone metabolism with endothelial dysfunction and vasculopathic changes in limited systemic sclerosisPhilipp Jud, Andreas Meinitzer, Heimo Strohmaier, et al.
Frontiers in Cardiovascular Medicine|February 24, 2022
Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data AnalysisPaul Gressenberger, Florian Posch, Moritz Pechtold, et al.
Frontiers in Cardiovascular Medicine|November 1, 2021
Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection-A Cross-Sectional StudyPhilipp Jud, Paul Gressenberger, Viktoria Muster, et al.
Scientific Reports|October 30, 2024
Lipoprotein (a) is not associated with thrombus burden derived from CT pulmonary angiography in patients with acute pulmonary embolismPaul Gressenberger, Florian Posch, Gabriel Adelsmayr, et al.
Journal of Personalized Medicine|July 2, 2021
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic SclerosisPaul Gressenberger, Philipp Jud, Gabor Kovacs, et al.
Rheumatology International|July 8, 2025
Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational studyPhilipp Jud, Philipp Douschan, Teresa Sassmann, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Seminars in Arthritis and Rheumatism|December 4, 2020
Prevalence and prognostic factors for aortic dilatation in giant cell arteritis - a longitudinal studyPhilipp Jud, Nicolas Verheyen, Christian Dejaco, et al.
International Journal of Clinical Practice|February 4, 2021
Effect of short-interval rituximab and high-dose corticosteroids on kidney function in systemic sclerosis: Long-term experience of a single centreBalazs Odler, Carina Hebesberger, Lukas Hoeflechner, et al.
Frontiers in Nutrition|April 9, 2026
Association of lipid parameters with the development of disease complications in patients with limited cutaneous systemic sclerosis: a prospective exploratory cohort studyLeyla Schweiger, Andreas Meinitzer, Heimo Strohmaier, et al.
Clinical and Experimental Rheumatology|July 29, 2021
Evaluation of endothelial dysfunction and clinical events in patients with early-stage vasculopathy in limited systemic sclerosisPhilipp Jud, Andreas Meinitzer, Heimo Strohmaier, et al.
Frontiers in Medicine|July 10, 2023
Association of amino acids and parameters of bone metabolism with endothelial dysfunction and vasculopathic changes in limited systemic sclerosisPhilipp Jud, Andreas Meinitzer, Heimo Strohmaier, et al.
Frontiers in Cardiovascular Medicine|February 24, 2022
Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data AnalysisPaul Gressenberger, Florian Posch, Moritz Pechtold, et al.
Frontiers in Cardiovascular Medicine|November 1, 2021
Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection-A Cross-Sectional StudyPhilipp Jud, Paul Gressenberger, Viktoria Muster, et al.
Scientific Reports|October 30, 2024
Lipoprotein (a) is not associated with thrombus burden derived from CT pulmonary angiography in patients with acute pulmonary embolismPaul Gressenberger, Florian Posch, Gabriel Adelsmayr, et al.
Journal of Personalized Medicine|July 2, 2021
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic SclerosisPaul Gressenberger, Philipp Jud, Gabor Kovacs, et al.
Rheumatology International|July 8, 2025
Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational studyPhilipp Jud, Philipp Douschan, Teresa Sassmann, et al.
Pageof 7